Perceived stigma and its correlates among Asian patients with advanced cancer: A multi‐country APPROACH study

Abstract

Objectives Perceived cancer‐related stigma can affect mental health and potentially treatment choices for patients with cancer. Nevertheless, perceived stigma is not very well understood in Asia. This study investigated across six developing Asian countries: (1) the prevalence of perceived stigma among advanced cancer patients, (2) its risk factors, and (3) its association with patient treatment preferences. Methods This cross‐sectional study recruited patients receiving oncology care across major hospitals in Bangladesh, China, India, Philippines, Sri Lanka and Vietnam. Participants (N = 1358) were adults diagnosed with stage IV metastatic solid cancer who completed self‐reported surveys. Multi‐variable logistic regression and ordered logit models examined the associations with perceived stigma and variables of interest. Results Across the countries, 35%, 95% CI [32%, 38%] of patients reported experiencing at least one facet of cancer‐related stigma often or always, while 60% [57%, 63%] reported it occurring occasionally. Top‐endorsed facets of perceived stigma across the Asian countries suggest a distinct pattern. Having knowingly engaged in health‐risk behaviours (OR = 2.03–2.24, 95% CI [1.14–1.19, 3.43–4.41]), unemployment (2.64 [1.67, 4.19]) and body image change (1.57 [1.00, 2.45]) were associated with higher odds of perceived stigma, while time mitigated perceived stigma (0.49–0.65 [0.30–0.45, 0.76–0.92]). Perceived stigma was associated with lower odds of preference for life‐extending treatments, although the associations did not hold up in the adjusted model. Conclusions Perceived stigma is unique among Asian advanced cancer patients. Stigma is important to assess and address, taking into consideration the various sociodemographic, clinical and psychological factors of cancer patients.

Is smoking acceptable for lung cancer patient? Factors influencing the stigmatization.

“…Smoking behavior was associated with higher stigma (i.e., lower acceptability judgments) toward a person with lung cancer, representing an additional burden for patients. Reducing the stigma becomes a priority, not only to optimize the participation to screening tests for lung cancer (Bernstein et al, 2022) but also to improve the follow-up of treatment, once diagnosed (Teo et al, 2022). Reducing this stigma has thus become essential for improving patient’s quality of life and survival (Banerjee et al, 2021; Kirby, 2020).…”

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey

“…A cross-sectional survey was conducted as part of the “Asian Patient Perspectives Regarding Oncology Awareness, Care and Health (APPROACH) project across nine LMICs in Asia. This larger project set out to investigate patients living with advanced cancer regarding various domains: HRQOL [ 33 ], quality of care [ 34 ], perceived and preferred levels of involvement in decision-making [ 35 ], understanding of prognosis [ 36 ], awareness and utilization of hospice palliative care services [ 37 ], mental health services [ 38 ], as well as cancer-related self-blame [ 39 ] and social stigma [ 40 ].…”

Life before Death in India: A Narrative Review

“…In a 2022 study done among cancer patients in six developing countries, including India, 35% of patients reported experiencing at least one facet of cancer-related stigma often, while 60% reported experiencing it occasionally; those who perceived stigma were less likely to opt for life-extending treatments. [ 25 ]…”